Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12611000907943Phase 3Recruiting
Phase 3, open-label, single-arm trial of granulocyte colony-stimulating factor in Endometrial hypotrophy and Refractory endometrium, sponsored by Fertility Specialists of Western Australia. Primary endpoints: Improvement in endometrial thickness and Live birth rate. Started Jul 2012; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12611000907943.